Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph phase_2
1
33%
Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

Withdrawn1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (50.0%)
Phase 21 (50.0%)

Trials by Status

withdrawn133%
unknown133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis

NCT07046988
withdrawnearly_phase_1

Terbinafine Treatment of Axial Spondyloarthropathy

NCT05119712
unknownphase_2

Efficacy and Safety of Terbinafine and Itraconazole

NCT05881980

Clinical Trials (3)

Showing 3 of 3 trials
NCT07046988

Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis

Recruiting
NCT05119712Early Phase 1

Terbinafine Treatment of Axial Spondyloarthropathy

Withdrawn
NCT05881980Phase 2

Efficacy and Safety of Terbinafine and Itraconazole

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3